ARTICLE | Company News
Nabi, GlaxoSmithKline deal
February 15, 2010 8:00 AM UTC
Nabi will receive an $8 million milestone payment from GlaxoSmithKline under a 2009 deal in which GSK acquired Nabi's PentaStaph pentavalent Staphylococcus aureus vaccine program and related assets. ...